Skip to content

David M. Wood

3 papers in the library · 156 citations · publishing 2017-2025

Papers

Novel psychoactive substances: types, mechanisms of action, and effects

BMJ January 25, 2017 Derek K. Tracy, David M. Wood, David Baumeister 117 citations

Over 900 distinct novel psychoactive substances (NPS) have been identified globally, with 85% distributed via the World Wide Web. These compounds, often mimicking cannabis, exert complex action on the brain, leading to severe adverse effects in 30% of users. Computer science aids discreet advertising, challenging Internet privacy and visitor pattern monitoring. Forensic Toxicology and Drug Analysis are vital for identification, informing Psychedelics and Drug Studies and Cannabis and Cannabinoid Research efforts to combat this evolving public health threat.

Acute recreational drug toxicity

Medicine January 31, 2018 Evangelia Liakoni, Chris Yates, Alison M. Dines et al. 38 citations

Self-reported substance use by patients arriving at emergency departments with acute recreational drug toxicity matches toxicological analysis best for heroin (86.1% agreement) and cocaine (74.1% agreement). Inhalants, poppers, and magic mushrooms were self-reported but never detected analytically. Immunoassays accurately identified methadone (100% agreement) and cocaine (95.5% agreement) but were less consistent for amphetamines (81.8% agreement). Mass spectrometry confirmed MDMA, amphetamine, methamphetamine, and new psychoactive substances in many cases where immunoassays were negative, and revealed multiple-substance use. Diagnosis of new psychoactive substance use relied primarily on self-report.

Differences in the clinical presentation of acute 3,4-methylenedioxymetamfetamine intoxication by co-intoxication and patient sex to European emergency departments.

Clinical toxicology (Philadelphia, Pa.) March 1, 2025 Joep J. J. Ouwerkerk, David M. Wood, Alison M. Dines et al. 1 citation

When 3,4-methylenedioxymetamfetamine (MDMA) is taken with alcohol, emergency department visits show higher odds of agitation, drowsiness, and vomiting compared to MDMA alone. Co-intoxication with other substances increases odds of bradycardia, psychosis, and coma. Mortality rates remain low across all groups. Female patients report less chest pain but more vomiting, headache, and hypotension than males. These variations suggest that physicians should consider both the type of co-intoxication and patient sex to optimize treatment.